Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

U S Physical Therapy (USPH) EBITDA Margin (2016 - 2025)

U S Physical Therapy's EBITDA Margin history spans 11 years, with the latest figure at 10.57% for Q2 2022.

  • For Q2 2022, EBITDA Margin fell 695.0% year-over-year to 10.57%; the TTM value through Mar 2023 reached 26.62%, up 1544.0%, while the annual FY2022 figure was 6.54%, 171.0% down from the prior year.
  • EBITDA Margin for Q2 2022 was 10.57% at U S Physical Therapy, up from 6.68% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 18.64% in Q3 2020 and bottomed at 33.46% in Q4 2019.
  • The 5-year median for EBITDA Margin is 12.98% (2021), against an average of 10.08%.
  • The largest annual shift saw EBITDA Margin tumbled -4608bps in 2019 before it skyrocketed 4870bps in 2020.
  • A 5-year view of EBITDA Margin shows it stood at 12.62% in 2018, then tumbled by -365bps to 33.46% in 2019, then skyrocketed by 146bps to 15.24% in 2020, then fell by -17bps to 12.68% in 2021, then fell by -17bps to 10.57% in 2022.
  • Per Business Quant, the three most recent readings for USPH's EBITDA Margin are 10.57% (Q2 2022), 6.68% (Q1 2022), and 12.68% (Q4 2021).